medline.ch Onkologie Magen-Darm

	Impact of direct transfer to critical care on mortality for patients who undergo emergency colorectal cancer resection: a national population-based cohort study in England. BJA Open Blake HA, Rashid A, Watton L, Kuryba A, Boyle JM, Vallance A, Berkman L, Harrison DA, Doidge J, Moonesinghe SR, Murray D, Hill J, Fearnhead NS, van der Meulen J, Sharples LD, Walker K. PMID: 42926795 [PubMed - as supplied by publisher]
	Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles. Discov Oncol Broni FK, George BP, Abrahamse H. PMID: 42926737 [PubMed]
	Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. medRxiv Zhai T, Pankratz VS, Zychowski KE, Li Y, Leslie KK, Guo Y, Amos CI, Cook LS, Leng S. PMID: 42926595 [PubMed]
	A randomized Phase 1 study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with bevacizumab versus trifluridine-tipiracil with bevacizumab in patients with metastatic colorectal cancer. Ann Oncol Cecchini M, Cruz-Correa M, Han SW, Raghav K, Landa-Magdalena A, Strickler JH, Calvo A, Hollebecque A, Nakajima TE, Perl G, Jain V, Hunter Z, Chan EM, Blaney M, Li R, Vasilopoulos A, Parikh A, Sharma MR. PMID: 42926107 [PubMed - as supplied by publisher]
	Final results of nivolumab plus ipilimumab versus nivolumab or chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW. Ann Oncol Lonardi S, Lenz HJ, Elez E, Jensen LH, Van Cutsem E, Touchefeu Y, García-Carbonero R, Tougeron D, Mendez GA, Schenker M, Fouchardière C, Mirón MLL, Yoshino T, Li J, Mozo JLM, Dahan L, Tortora G, Chalabi M, Goekkurt E, Braghiroli MI, Joshi R, Cil T, Aubin F, Raparthi V, Wang A, Rodriguez S, Cela E, Li L, Tam R, Jin L, André T. PMID: 42926106 [PubMed - as supplied by publisher]
	14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan. Lancet Sakakida T, Taniguchi H, Asayama M, Suwa Y, Shimura T, Mitani S, Makiyama A, Arai H, Matsuoka H, Yokota M, Takano Y, Kato K, Oda H, Kajiwara T, Ogawa K, Shibata N, Sawada K, Yomoda T, Kudo T, Okuda H, Okumura Y, Tanaka C, Nakamura M, Tsuda T, Kitajima T, Tsukuda H, Shinozaki E, Furuta M, Kashiwada T, Okuya K, Mushiake H, Hasegawa J, Nihei K, Mizushima T, Mine T, Mizukami T, Kudo C, Mishima A, Murotani K, Masuishi T, PRABITAS investigators. PMID: 42925880 [PubMed - as supplied by publisher]
	Descriptive survival outcomes of fruquintinib-based PD-1 inhibitor strategies in advanced colorectal cancer reported as pMMR/MSS: a reconstructed-data analysis of prospective studies. Cancer Treat Res Commun Ge Y, Xia Y, Lin GH, Fu C, Kuang BH, Wang BC. PMID: 42925845 [PubMed - as supplied by publisher]
	Incorporating visceral adipose tissue into dual-region deep learning radiomics on CT improves preoperative lymph node metastasis prediction in gastric cancer: A multicenter study. Eur J Radiol Miao S, Xiong Z, Yang H, Zhang L, Qi H, Liu Z, Wang Q, Ding X, Wang R, Lu P. PMID: 42925841 [PubMed - as supplied by publisher]
	Japanese Society for Hereditary Tumors Guidance: Hereditary Cancer Syndromes With Multigene Panel Testing, 2025 Edition. Cancer Sci Yoshida R, Hirasawa A, Imoto I, Yamaguchi T, Kumamoto K, Momoko A, Ueki A, Masuda K, Urakawa Y, Tanabe N, Watanabe A, Hirata M, Aruga T, Kuwata T, Okugawa Y, Kaneko K, Terui-Kohbata H, Matsumoto M, Ueno S, Oda K, Ono H, Sakurai A, Matsui H, Yamamoto G, Yamamoto H, Yamamoto Y, Ikegami M, Ohkuma Y, Shien K, Suzuki S, Takayanagi S, Tanabe M, Hasumi H, Hatta N, Hattori H, Matsubayashi H, Yamagami W, Yamada M, Oishi K, Oka T, Oda S, Kobayashi Y, Takekoshi K, Nakajima T, Nakano Y, Nakayama Y, Miura F, Miyakura Y, Mori Y, Yoshimura A, Yonamine M, Shigeyasu K, Fujita H, Futagawa M, Ohta K, Kawano J, Tokutomi T, Sato A, Makabe T, Yoshihama T, Aitani M, Kimura K, Takaiso N, Tomozawa C, Hiraoka Y, Matsukawa M, Ishida H. PMID: 42925246 [PubMed - as supplied by publisher]
	Multimodal prehabilitation in colorectal cancer surgery: randomized clinical trial. BJS Open Bjerregaard F, Pekkari K, Asklid D, Anderin C, Westberg K, Marsk R, Gustafsson UO. PMID: 42925093 [PubMed - indexed for MEDLINE]
	Measures of physical fitness and postoperative mortality in patients with colorectal cancer: national cohort study. BJS Open Rashid A, Blake HA, Watton L, Fearnhead NS, Han L, van der Meulen J, Walker K. PMID: 42925090 [PubMed - indexed for MEDLINE]
	Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeuticÂ implications (Review). Int J Mol Med Zhang T, Ren Z, Wang L, Man R, Wang L, Wang J, Cheng X, Peng J, Yu Y. PMID: 42924590 [PubMed - indexed for MEDLINE]
	The Economic Value of Hereditary Cancer Testing: A Systematic Review. Genet Med Kirshner C, Carter GC, Heald B, Hartzfeld D, Johnson H, Xiao J, Kong J, Thompson G, Sancar F, Peters ML. PMID: 42924496 [PubMed - as supplied by publisher]
	Integrative Untargeted Metabolomics, Network Pharmacology, and Molecular Docking Identify Candidate Anti-Gastric Cancer Mechanisms of Zhishi Dahuang Decoction. Biomed Chromatogr Zhang L, Zhao X, Shi B, Zhou N, Xiong D, Chen X, Ji L, Shen Q, Lv Y. PMID: 42924494 [PubMed - indexed for MEDLINE]
	Robot-assisted radical surgery for colorectal cancer: technical advances, lymphadenectomy, natural orifice specimen extraction, and ongoing controversies. Front Surg Liu W, Ma Z, Xie J, Wu X, Baheen QA, Zhang S, Liu Z. PMID: 42924242 [PubMed]
	Routes to Diagnosis and Stage at Diagnosis of Colorectal Cancer in Patients Aged â‰¥ 50 Years: A Multicentre Retrospective Cohort Study From North Wales, UK. Cureus Toquero M, Thiagarajah Naidu S, Williams AD, Waddon J, Emmas R, Das A, Noor A, Balasubaramaniam V, Dixon S. PMID: 42923923 [PubMed]
	Serum metabolomic signatures associated with gastric signet-ring cell carcinoma: A dual-platform mass spectrometry study. Oncol Lett Cao H, Guo S, Li J, Bian Y, Shen J, Wang J, Meng F, Sun W, Sun Q, Gu W. PMID: 42923593 [PubMed]
	Efficacy and safety of postoperative chemotherapy with capecitabine and oxaliplatin for advanced gastric cancer. Am J Transl Res Wang J, Li Y, Wang H, Cai X. PMID: 42923190 [PubMed]
	LLM-assisted evidence audit of late-stage cancer incidence as a screening trial endpoint. medRxiv Li S, Zhang W, Xing X, Shen Z, Wang Y, Chen Z, Neto OBL, Yu Y, Wu C, Lin L. PMID: 42922838 [PubMed]
	The Role of Distress-related Metabolic Dysfunction in Ovarian Cancer Development: a pooled case-control study. medRxiv Lin N, Balasubramanian R, Menichetti G, Eliassen AH, Trabert B, Avila-Pacheco J, Townsend MK, Terry KL, Clish CB, Tworoger SS, Zeleznik OA. PMID: 42922603 [PubMed]

Artikel 1 - 20 / 246461

Seite 1 von 12324

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung